Aquis AQSE - Delayed Quote GBp

Incanthera plc (INC.AQ)

1.5001 -0.4949 (-24.81%)
At close: 13 July at 15:07:44 BST
Chart Range Bar
Loading chart for INC.AQ
  • Previous close 1.9950
  • Open 2.2000
  • Bid --
  • Ask --
  • Day's range 1.5001 - 2.2000
  • 52-week range 0.0050 - 2.2750
  • Volume 434,598
  • Avg. Volume 227,399
  • Market cap (intra-day) 2.069M
  • Beta (5Y monthly) 0.62
  • PE ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings date (est.) --
  • Forward dividend & yield --
  • Ex-dividend date --
  • 1y target est --

Incanthera plc, a dermatology and oncology therapeutics company, engages in the dermatological formulation and delivery technologies for various indications. The company develops skincare products under the Skin + CELL brand name. Incanthera plc was founded in 2010 and is headquartered in Manchester, the United Kingdom.

www.incanthera.com

8

Full-time employees

31 March

Fiscal year ends

Healthcare

Sector

Biotechnology

Industry

Performance overview

Trailing total returns as of 14/07/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD return

INC.AQ
6,283.40%
MSCI WORLD (^990100-USD-STRD)
9.22%

1-year return

INC.AQ
2,900.20%
MSCI WORLD (^990100-USD-STRD)
19.43%

3-year return

INC.AQ
2,190.23%
MSCI WORLD (^990100-USD-STRD)
60.34%

5-year return

INC.AQ
1,090.56%
MSCI WORLD (^990100-USD-STRD)
58.20%

Statistics

View more

Valuation measures

As of 10/07/2026
  • Market cap

    2.41M

  • Enterprise value

    2.20M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG ratio (5-yr expected)

    --

  • Price/sales (ttm)

    358.72

  • Price/book (mrq)

    3.19

  • Enterprise value/revenue

    366.49

  • Enterprise value/EBITDA

    --

Financial highlights

Profitability and income statement

  • Profit margin

    0.00%

  • Return on assets (ttm)

    -66.85%

  • Return on equity (ttm)

    -170.49%

  • Revenue (ttm)

    6k

  • Net income avi to common (ttm)

    -2.27M

  • Diluted EPS (ttm)

    -0.0200

Balance sheet and cash flow

  • Total cash (mrq)

    215k

  • Total debt/equity (mrq)

    --

  • Levered free cash flow (ttm)

    -850.75k

Compare

Select to analyse similar companies using key performance metrics; select up to four stocks.

People also watch